←Back to list

Vedana Therapeutics

Developing new therapies for migraine prevention.
Developing new therapies for migraine prevention. Headquartered in Seattle, WA. Raised $46M in Series A funding in June 2026 led by Westlake BioPartners.
Biotechnology 📍 Seattle, WA
Current Valuation
Private
PRIVATE

IPO Outlookprivate

Is Vedana Therapeutics going public?
No. Vedana Therapeutics is private and has not filed to go public. There is no S-1 on file.
What is Vedana Therapeutics' valuation in 2026?
No confirmed valuation is on record for Vedana Therapeutics. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Vedana Therapeutics filed an S-1?
No public S-1 is on file for Vedana Therapeutics.
Who are Vedana Therapeutics' investors?
Vedana Therapeutics' investors include Westlake BioPartners, Canaan Partners, Dawn Biopharma, Alexandria Venture Investments.
How much has Vedana Therapeutics raised?
Vedana Therapeutics has raised $46M in total across 1 disclosed round, most recently a Series A of $46M in Jun 2026.
Is Vedana Therapeutics publicly traded — can you buy Vedana Therapeutics stock?
No. Vedana Therapeutics is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Vedana Therapeutics on its Pre-IPO Access Desk.
How to actually get exposure to Vedana Therapeutics →
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

CEO
Anurag Agrawal
HQ
Seattle, WA
Total Raised
$46M
Last Round
Series A — $46M (Jun 2026) · Lead: Westlake BioPartners
IPO Status
private

Fundraising Status

Series A · $46M · 3 mo ago
privateTotal raised $46M1 disclosed rounds

Funding History

RoundAmountDateLead InvestorPost-Money
Series A$46MJun 2026Westlake BioPartners—

Vertical Intelligence — Biotech / Gene Therapy

No name-verified sponsor record on ClinicalTrials.gov for Vedana Therapeutics — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-09-19. Re-checked weekly.

Talent Signal

No public careers page or job board could be found for Vedana Therapeutics as of 2026-09-14. That itself is a datapoint: no open external hiring surface.
Checked the company site and major hosted job boards. Re-checked monthly.

Investors

Westlake BioPartners · Canaan Partners · Dawn Biopharma · Alexandria Venture Investments
BiotechnologyTherapeuticsRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.